SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jenni Hyysalo, Ville T. Männistö, You Zhou, Johanna Arola, Vesa Kärjä, Marja Leivonen, Anne Juuti, Nabil Jaser, Susanna Lallukka, Pirjo Käkelä, Sari Venesmaa, Marko Simonen, Juha Saltevo, Leena Moilanen, Eeva Korpi-Hyövalti, Sirkka Keinänen-Kiukaanniemi, Heikki Oksa, Marju Orho-Melander, Luca Valenti, Silvia Fargion, Jussi Pihlajamäki, Markku Peltonen, Hannele Yki-Järvinen, A population-based study on the prevalence of NASH using scores validated against liver histology, Journal of Hepatology, 2014, 60, 4, 839

    CrossRef

  2. 2
    L. Fedchuk, F. Nascimbeni, R. Pais, F. Charlotte, C. Housset, V. Ratziu, Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2014, 40, 10
  3. 3
    Mariana V. Machado, Helena Cortez-Pinto, Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal, Journal of Hepatology, 2013, 58, 5, 1007

    CrossRef

  4. 4
    Y. Yilmaz, Review article: non-alcoholic fatty liver disease and osteoporosis – clinical and molecular crosstalk, Alimentary Pharmacology & Therapeutics, 2012, 36, 4
  5. You have free access to this content5
    J. K. Dowman, J. W. Tomlinson, P. N. Newsome, The diagnosis of non-alcoholic fatty liver disease: authors' reply, Alimentary Pharmacology & Therapeutics, 2012, 35, 1